O'Brien W M, Grunwaldt E
Scand J Rheumatol Suppl. 1976;1976(0):105-10.
In a two week double-blind cross-over trial of ketoprofen versus placebo in twelve patients, ketoprofen was shown to have substantial anti-inflammatory activity and to be more effective than placebo. Clinical and biological tolerance were excellent.
在一项针对12名患者的酮洛芬与安慰剂的双盲交叉试验中,为期两周,结果显示酮洛芬具有显著的抗炎活性,且比安慰剂更有效。临床和生物学耐受性良好。